SEI INVESTMENTS CO - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 52 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2023$326,303
-2.0%
9,069
+21.4%
0.00%0.0%
Q4 2022$332,938–7,470
+53257.1%
0.00%–
Q1 2019$0–14–0.00%–
 Download
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q2 2019.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders